RT Journal Article
SR Electronic
T1 Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staffs Protection during the Coronavirus Disease 2019 Outbreak
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.25.20028043
DO 10.1101/2020.02.25.20028043
A1 Yanfang Jiang
A1 Haifeng Wang
A1 Likun Chen
A1 Jiaxue He
A1 Liguo Chen
A1 Yong Liu
A1 Xinyuan Hu
A1 Ang Li
A1 Siwen Liu
A1 Peng Zhang
A1 Hongyan Zou
A1 Shucheng Hua
YR 2020
UL http://medrxiv.org/content/early/2020/02/27/2020.02.25.20028043.abstract
AB Background The outbreak of coronavirus disease 2019 (COVID-19) and SARS-CoV-2 have placed unprecedented challenges on hospital environmental hygiene and medical staffs protection. It is crucial to assess hospital environmental hygiene to understand the most important environmental issues for controlling the spread of 2019-nCoV in hospitals.Objective To detect the presence of the COVID-19 in the air and on the surfaces of the guide station, fever clinic, and isolation areas, and the close contacts medical staffs in the First Hospital of Jilin University.Methods Viruses in the air were collected by natural sedimentation and air particle sampler methods. Predetermined environmental surfaces were sampled using swabs at seven o’clock in the morning before disinfection. The samples from close contacts medical staffs were throat swab samples. Quantitative real-time PCR methods were used to confirm the existence of COVID-19 pathogens.Results Viruses could be detected on the surfaces of the nurse station in the isolation area with suspected patients and in the air of the isolation ward with an intensive care patient.Conclusion Comprehensive monitoring of hospital environmental hygiene during pandemic outbreaks is conducive to the refinement of hospital infection control. It is of great significance to ensure the safety of medical treatment and the quality of hospital infection control through the monitoring of environmental hygiene.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe National Natural Science Foundation of China (Nos. 30972610 and 81273240), Jilin Province Science and Technology Agency (Nos. 20160101037JC, 20170622009JC, 2017C021, and 2017J039), Norman Bethune Program of Jilin University (2012206), and Open Project Funding from State Key Laboratory of Kidney Diseases.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, models, and code generated or used during the study appear in the submitted article.